Viveve Medical, Inc.
VIVE · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $115 | $74 | $48 | $326 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $115 | $74 | $48 | $326 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.3% | -16.6% | -64.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 9.6% | 5.4% | 15.5% | 39.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -305.5% | -352.7% | -467.2% | -238.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -342.8% | -400% | -647.6% | -265.6% |
| EPS Diluted | -2.65 | -16.56 | -121.91 | -1,583.5 |
| % Growth | 84% | 86.4% | 92.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |